HealthEquity, Inc. (NASDAQ:HQY) Stock Rated “Moderate Buy” by Wall Street Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $113.53.

A number of brokerages recently weighed in on HQY. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Barclays increased their target price on shares of HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, September 18th. Raymond James Financial reissued a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. Finally, BMO Capital Markets boosted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st.

HealthEquity Trading Up 1.4%

NASDAQ HQY opened at $103.54 on Wednesday. HealthEquity has a 12 month low of $72.76 and a 12 month high of $110.26. The stock has a 50-day simple moving average of $95.78 and a 200 day simple moving average of $89.69. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $8.56 billion, a PE ratio of 37.38, a P/E/G ratio of 1.61 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. The firm had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts forecast that HealthEquity will post 3.94 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in HealthEquity during the 2nd quarter worth about $1,018,621,000. Wasatch Advisors LP lifted its stake in HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after acquiring an additional 757,801 shares in the last quarter. William Blair Investment Management LLC bought a new stake in HealthEquity in the 2nd quarter valued at approximately $160,158,000. Dimensional Fund Advisors LP lifted its stake in HealthEquity by 2.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock valued at $135,957,000 after acquiring an additional 45,287 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in HealthEquity during the 2nd quarter worth approximately $103,573,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.